These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 3052987

  • 1. Inhibition of drug metabolism by quinolone antibiotics.
    Edwards DJ, Bowles SK, Svensson CK, Rybak MJ.
    Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
    [Abstract] [Full Text] [Related]

  • 2. Overview of drug interactions with the quinolones.
    Davey PG.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():97-107. PubMed ID: 3053579
    [Abstract] [Full Text] [Related]

  • 3. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Drugs; 1987 Sep; 34 Suppl 1():159-69. PubMed ID: 3481317
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA.
    Am J Med; 1992 Apr 06; 92(4A):22S-25S. PubMed ID: 1580270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The influence of quinolone derivatives on theophylline clearance.
    Wijnands WJ, Vree TB, van Herwaarden CL.
    Br J Clin Pharmacol; 1986 Dec 06; 22(6):677-83. PubMed ID: 3567014
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Dec 06; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 9. Drug interactions with quinolone antibacterials.
    Brouwers JR.
    Drug Saf; 1992 Dec 06; 7(4):268-81. PubMed ID: 1524699
    [Abstract] [Full Text] [Related]

  • 10. 4-quinolones inhibit biotransformation of caffeine.
    Harder S, Staib AH, Beer C, Papenburg A, Stille W, Shah PM.
    Eur J Clin Pharmacol; 1988 Dec 06; 35(6):651-6. PubMed ID: 2853056
    [Abstract] [Full Text] [Related]

  • 11. Interaction between the fluoroquinolones and the bronchodilator theophylline.
    Wijnands WJ, Vree TB.
    J Antimicrob Chemother; 1988 Sep 06; 22 Suppl C():109-14. PubMed ID: 3053575
    [Abstract] [Full Text] [Related]

  • 12. Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
    Polk RE.
    Am J Med; 1989 Nov 30; 87(5A):76S-81S. PubMed ID: 2686430
    [Abstract] [Full Text] [Related]

  • 13. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, Rüsing G, Labedzki A, Bulitta J, Sörgel F.
    Clin Pharmacol Ther; 1999 Mar 30; 65(3):262-74. PubMed ID: 10096258
    [Abstract] [Full Text] [Related]

  • 14. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics.
    Sörgel F, Mahr G, Granneman GR, Stephan U, Nickel P, Muth P.
    Clin Pharmacokinet; 1992 Mar 30; 22 Suppl 1():65-74. PubMed ID: 1319873
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G, Segura J, de la Torre R, Carbó M.
    Eur J Clin Pharmacol; 1990 Mar 30; 39(1):63-9. PubMed ID: 2177401
    [Abstract] [Full Text] [Related]

  • 16. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
    Mahr G, Sörgel F, Granneman GR, Kinzig M, Muth P, Patterson K, Fuhr U, Nickel P, Stephan U.
    Clin Pharmacokinet; 1992 Mar 30; 22 Suppl 1():90-7. PubMed ID: 1319876
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic interactions between theophylline and other medication (Part I).
    Upton RA.
    Clin Pharmacokinet; 1991 Jan 30; 20(1):66-80. PubMed ID: 1674242
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
    Fuhr U, Anders EM, Mahr G, Sörgel F, Staib AH.
    Antimicrob Agents Chemother; 1992 May 30; 36(5):942-8. PubMed ID: 1510417
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR, Ljungberg B.
    Rev Infect Dis; 1989 May 30; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [Abstract] [Full Text] [Related]

  • 20. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
    Sarkar M, Polk RE, Guzelian PS, Hunt C, Karnes HT.
    Antimicrob Agents Chemother; 1990 Apr 30; 34(4):594-9. PubMed ID: 2344166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.